Searchable abstracts of presentations at key conferences in endocrinology

ea0056p1076 | Thyroid (non-cancer) | ECE2018

Effectiveness of radioiodine treatment for toxic adenoma

Sofia Osorio Ana , Filipa Martins Ana , Vaz de Castro Raquel , Gomes Vania , Faria Carolina , Nobre Ema , Antoine Ferreira Mickael , Cantinho Guilhermina , Joao Bugalho Maria

Objective: The purpose of this study was to assess clinical outcomes of patients with toxic adenoma (TA) treated with Radioactive Iodine (RAIT) in a tertiary hospital over a period of 8 years. We also analysed the influence of age, gender, TSH at diagnosis and anti-thyroid drugs (ATD) previous to RAIT on the cure rate.Methods: Retrospective analysis of clinical records of all patients with TA submitted to RAIT between 2008 and 2015. The influence of demo...

ea0056p1078 | Thyroid (non-cancer) | ECE2018

Diminished levels and defective suppression function of Tr1 cells is observed in patients with autoimmune thyroiditis

Sampedro-Nunez Miguel , Vitales-Noyola Marlen , Serrano-Somavilla Ana , Martinez-Hernandez Rebeca , Aguirre Nerea , Fernandez Elena , Maria Ramos-Levi Ana , Gonzalez-Amaro Roberto , Marazuela Monica

Context: T regulatory type 1 (Tr1) cells are a subpopulation of T lymphocytes (CD4+CD49+LAG-3+IL-10+) lymphocytes that exerts a significant immunosuppressive effect. However, its possible role in autoimmune thyroid disease (AITD) had not been explored so far.Objective: To analyze the levels and function of Tr1 cells in peripheral blood and thyroid tissue of patients with AITD.Design: Cases and controls, observational study.<p c...

ea0056p1093 | Thyroid (non-cancer) | ECE2018

Should tocilizumab be a second-line treatment of active, moderate-to-severe Graves’ Orbitopathy?

Caceres Rocio , Herrero Ana , Recio-Cordova Jose Maria , Sanchez-Marcos Ana , Higueruela Cecilia , Beaulieu Myriam , Iglesias Rosana , Robles Cristina , Garcia-Duque Maria , Corrales-Hernandez Juan Jose

Introduction: Graves’ orbitopathy (GO) is the most common extrathyroidal manifestation of Graves’ disease. The first-line treatment are intravenous corticoids in active moderate-severe GO. Tocilizumab is a humanized monoclonal antibody against the IL-6 receptor which has been approved for the treatment of rheumatoid arthritis and is in its research stage for patients with corticosteroid-refractory GO.Objectives: To assess the experience with to...

ea0073pep15.5 | Presented ePosters 15: Late Breaking | ECE2021

Pheochromocytoma secreting IL-6; an atypical presentation

Laura García María , Lisdero Ana Paula , González Pernas Mariana , Speroni Romina , Segarra Ana , Otero Jimena , Genovesi Elbio , Belli Susana , Giselle Mumbach Aizhar

Pheochromocytoma (PCC) is a rare tumor that arises from the adrenal medulla, usually presents with headache, sweating and palpitations due to excessive catecholamine release. However, PCC may secrete neuropeptides, hormones and cytokines, such as interleukin-6 (IL-6)) resulting in unusual clinical manifestations. A 48-year-old woman with a previous history of type 1 neurofibromatosis (NF1) and hypertension was referred to discarded PCC. Laboratory tests revealed leukocytosis a...

ea0073aep756 | Thyroid | ECE2021

Papillary thyroid cancer presenting with splenic infarction

Saraiva Miguel , Magda Garça , Rita Costa Ana , Pinheiro Guiomar , Rita Cruz Ana , Ribeiro Sofia , Cláudia Freitas , André Carvalho

IntroductionThe close relationship between cancer and thrombotic phenomena has been widely recognized and paraneoplastic organ infarctions may occur. Reports of papillary thyroid cancer associated to paraneoplastic phenomena are particularly scarce.Case reportA 39-year-old man with no prior relevant medical history was evaluated for acute onset of fever, malaise and mild pain referred to his left hypochondriu...

ea0073aep876 | Late Breaking | ECE2021

Influence of bitter taste gene TAS2R38 on endocrinometabolic and anthropometric parameters in a sample with thyroid disease

Mendes Costa Marta , Carolina Santos Ana , Ferreira Joana , Mário Rui Mascarenhas , Bicho Manuel , Paula Barbosa Ana , Alda Pereira da Silva

Background and objectivesTAS2R38 is a bitter taste gene that can influence food consumption depending on its single nucleotide polymorphisms (SNPs) leading to aminoacid substitutions in the receptor protein P49A (proline/alanine), A262V (alanine/valine) e V296I (valine/isoleucine). Subjects with at least one PAV (proline-alanine-valine) copy are bitter tasters, while AVI homozygotes are non-tasters. Other variants have intermediate bitter tasting: AAV&#6...

ea0092ps3-30-08 | Thyroid Physiology in Periphery &amp; Development Basic | ETA2023

Identification of FOXE1 promoter variants in families with cleft palate, struma ovarii and thyroid lesions

Pires Carolina , Saramago Ana , M. Moura Margarida , Li Jing , Marques Ines , Cabrera Rafael , Machado Ana , Grunewald Thomas , Leite Valeriano , Cavaco Branca

Introduction: Forkhead box E1 (FOXE1) gene encodes a transcription factor crucial for thyroid morphogenesis, differentiation, and function. We previously found evidence of the involvement of a rare germline FOXE1 variant in familial non-medullary thyroid carcinoma (FNMTC) etiology. FNMTC most common subtype is papillary thyroid carcinoma (PTC), and family members frequently present thyroid follicular nodular disease (FND). Germline FOXE1 mu...

ea0099p382 | Thyroid | ECE2024

Antithrombotic/anticoagulant drugs did not increased the risck of bleeding during thyroid fna (nor it´s whithdrawal up to one month reduced it´s risk)

Roque Catarina , Correia Claudia , Silva Sandra , Caldeira, Nurse Andreia , Valadares, Nurse Ricardo , Paula Fernandes, Nurse Ana , Barreiros, Nurse Filipa , Osorio Ana , Oliveira Sofia , Fonseca Ricardo

Introduction: Thyroid fine-needle aspiration cytology (TFNA) is a widely used diagnostic method that is generally safe. Aiming to reduce haemorrhage doctors frequently advise patients to withdrawal antithrombotic/anticoagulant (AT/AC) drugs before TFNA. There are no guidelines recommending so and the so called ‘novel anticoagulants’ have been poorly studied in this context. Some patients are likely being exposed to increased thrombotic risk unnecessarily. Evidence is...

ea0055wa13 | Workshop A: Disorders of the hypothalamus and pituitary (I) | SFEEU2018

Cushing’s disease relapse associated with central diabetes insipidus

Ferreira Ana , Silva Tiago , Bastos Filipa , Manita Isabel , Cordeiro Maria Carlos , Portugal Jorge

Introduction: Central diabetes insipidus (DI) is a frequent complication of transfenoidal surgery for Cushing’s disease (CD). It can be transient or, more infrequently, permanent. The most common mechanism results from surgical neurohypophyseal damage rather than local mass effect from the pituitary adenoma.Case report: A 40 years old woman was referred to our Endocrinology outpatient clinic at the beginning of 2015 for new onset hypertension, signi...

ea0081yi9 | Young Investigator Awards | ECE2022

Acute kidney injury: a strong risk factor for hypoglycaemia in hospitalized patients with type 2 Diabetes

Carreira Ana , Castro Pedro , Mira Filipe , Melo Miguel , Paiva Isabel , Ribeiro Pedro , Santos Lelita

Introduction: Acute Kidney Injury (AKI) is highly prevalent during hospitalization of patients with type 2 diabetes (T2D), and has been associated with increased risk of hypoglycaemia in Intensive Care Units. However, this association in non-critically ill patients is less clear and evidence on the impact of AKI’s severity and duration on hypoglycaemia is lacking.Objectives: To assess the impact of AKI and its severity and duration on the risk of hy...